Research in Health Science (RHS) is an international, double-blind peer-reviewed, open-access journal which is published by Scholink. The journal aims to promote excellence through dissemination of high-quality research findings, specialist knowledge, and discussion of professional issues that reflect the diversity of this field. We would welcome scholars and researchers engaging in the related field to submit your manuscripts which are complete unpublished and original works and not under review in any other journals to Research in Health Science. Both of online submission and E-mail submission (rhs@scholink.org) are acceptable. The scopes of the journal include the following topics: public health health psychology community health health information mental health behavioral health environmental health healthcare nursing nutrition health policy health services health economics health protection health education The journal is included in: Academic Journal Articles Bielefeld Academic Search Engine (BASE) CiteFactor CNKI Scholar CrossRef Directory of Research Journals Indexing (DRJI) Electronic Journals Library (EZB) Globethics.net Journalseek JournalTOCs OCLC- WorldCat Open J-Gate Publons Refseek academic search engine ResearchBib Scientific Indexing Service (SIS) The Scientific Literature Database (Scilit) Standard Periodical Directory WZB Library Open access: Research in Health Science is available online to the reader "without financial, legal, or technical barriers other than those inseparable from gaining access to the internet itself". Peer review: Research in Health Science takes peer review policy. Peer review is the evaluation of work by one or more people of similar competence to the producers of the work (peers).
Authors who publish with this journal must agree to the following terms: Copyrights for articles published in our are retained by the authors. Authors should promise that their works are entirely original, and all the references in their works should be appropriately cited or quoted. The works have not been published previously. The behavior of submitting the same work to other journals is unacceptable. The journal editor has the right to edit the format of works.
Race, Ethnicity, Socioeconomic Status, and Chronic Lung Disease in the U.S.
Background: Higher socioeconomic status (SES) indicators such as educational attainment and income reduce the risk of chronic lung diseases (CLDs) such as Chronic Obstructive Pulmonary Disease (COPD), emphysema, chronic bronchitis, and asthma. Marginalization-related Diminished Returns (MDRs) refer to smaller health benefits of high SES for marginalized populations such as racial and ethnic minorities compared to the socially privileged groups such as non-Hispanic Whites. It is still unknown, however, if MDRs also apply to the effects of education and income on CLDs. Purpose: Using a nationally representative sample, the current study explored racial and ethnic variation in the associations between educational attainment and income and CLDs among American adults. Methods: In this study, we analyzed data (n = 25,659) from a nationally representative survey of American adults in 2013 and 2014. Wave one of the Population Assessment of Tobacco and Health (PATH)-Adult study was used. The independent variables were educational attainment (less than high school = 1, high school graduate = 2, and college graduate = 3) and income (living out of poverty = 1, living in poverty = 0). The dependent variable was any CLDs (i.e., COPD, emphysema, chronic bronchitis, and asthma). Age, gender, employment, and region were the covariates. Race and ethnicity were the moderators. Logistic regressions were fitted to analyze the data. Results: Individuals with higher educational attainment and those with higher income (who lived out of poverty) had lower odds of CLDs. Race and ethnicity showed statistically significant interactions with educational attainment and income, suggesting that the protective effects of high education and income on reducing odds of CLDs were smaller for Blacks and Hispanics than for non-Hispanic Whites. Conclusions: Education and income better reduce the risk of CLDs among Whites than Hispanics and Blacks. That means we should expect disproportionately higher than expected risk of CLDs in Hispanics and Blacks with high SES. Future research should test if high levels of environmental risk factors contribute to the high risk of CLDs in high income and highly educated Black and Hispanic Americans. Policy makers should not reduce health inequalities to SES gaps because disparities sustain across SES levels, with high SES Blacks and Hispanics remaining at risk of health problems.
Copyright (c) 2025 Shervin Assari, Hamid Chalian, Mohsen Bazargan http://creativecommons.org/licenses/by/4.0
Wearable UV Devices for Sun Protection: Practicalities, Utilities, and Limitations
Wearable ultraviolet (UV) devices present a promising innovation in personalized sun protection by providing continuous, real-time monitoring of UV radiation exposure. These devices are equipped with advanced sensors capable of detecting multiple UV wavelengths and offer seamless integration with mobile health platforms to deliver personalized recommendations, such as reminders for sunscreen reapplication based on individual exposure levels. Practical applications extend to diverse populations, accounting for factors such as varying skin types, environmental conditions, and long-term user adherence. The utility of these devices lies not only in their ability to enhance sun safety behaviors but also in potentially reducing the incidence of UV-induced skin damage, including sunburn, photoaging, and skin cancer. However, several limitations persist, including calibration drift over time, inaccuracies due to environmental interference (e.g., sweat, humidity, clothing), and inconsistent performance across different Fitzpatrick skin types. The effectiveness of these devices can also be influenced by user compliance, socioeconomic disparities, and the need for improved public education on proper usage. Moreover, accessibility challenges, particularly in underserved populations, raise concerns about equitable distribution of this technology. While wearable UV devices offer considerable potential in augmenting existing photoprotection measures, further large-scale clinical validation studies are required to refine their accuracy, reliability, and usability across broader demographic groups. Enhanced integration with teledermatology and public health initiatives may further strengthen the role of these devices in comprehensive sun protection strategies.
Copyright (c) 2025 Grace Herrick, Kelly Frasier, Erin Lowe http://creativecommons.org/licenses/by/4.0
AI Positioning and Navigation, Robot Operation, Precise Intervention of Chemotherapy Drugs into the Osteolytic Destruction Area of the Distal Femoral Metaphysis, Implementing Direct Chemotherapy within the Solid Tumor of Osteosarcoma
MAP regimen is a classic chemotherapy protocol for osteosarcoma. On the basis of MAP reginen, we have made three adjustments and ultimately developed an innovative regimen for direct chemotherapy in the solid tumor of osteosarcoma specifically tailored for this patient: 1). Adjust the drug supply method from intravenous infusion to static pulse injection pump micro-volume slow push 2). By AI positioning navigation, robot operation, static pulse injection pump micro-volume slow push, the chemotherapy drugs are accurately involved into the osteolytic destruction area of osteosarcoma, and implementing direct chemotherapy in the solid tumor of osteosarcoma. 3). Combined with autologous leukocyte implantation The patient successfully completed the direct chemotherapy in the solid tumor of osteosarcoma, combined with autologous leukocyte implantation for 4 cycles before operation, the tumor volume was reduced by about 50%, tumor was sensitive to chemotherapy, with a tumor necrosis rate of over 90%, the clinical stage has been downstaged from IIA to a potentially resectable status, with clear boundaries and no distant metastasis, providing a favorable condition for surgical resection. Compared to targeted therapy and nanotechnology, this is a more direct and more precise approach to intratumoral chemotherapy. It indeed can increase the concentration of chemotherapeutic drugs within tumors by focusing drug delivery to the tumor site, enhancing the direct killing effect on tumor targets while potentially reducing systemic side effects. The next step in the research plan is to implement direct chemotherapy in the solid tumor of malignant bone tumor while combining it with animal leukocyte transplantation, fully utilizing the particularity of immune rejection under the condition of confined space in a solid tumor to destroy the tumor microenvironment.
Copyright (c) 2026 Jianchen Lin http://creativecommons.org/licenses/by/4.0